Allergan plcAGN:NYQ

231.26
3.54 / 1.55%
3.18m
22.72 %
0.6969
Latest price in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jun 29 2016 18:53 BST.

Summary

As of last trade, Allergan plc (AGN:NYQ) traded at 231.26, 18.29% above the 52 week low of 195.50 set on May 06, 2016.

52-week range
Today
195.50
May 06 2016
340.34
Jul 29 2015
Markit short selling activity
Low
Medium
High
Open230.80
Day high234.55
Day low227.72
Bid231.12
Offer231.27
Previous close227.72
Average volume3.46m
Shares outstanding395.56m
Free float394.87m
P/E (TTM)--
Market cap90.08bn USD
EPS (TTM)-5.6261 USD
Data delayed at least 15 minutes, as of Jun 29 2016 18:53 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Allergan plc+1.19 %-1.98 %-26.60 %-22.72 %+239.24 %
S&P 500 INDEX-2.37 %-3.00 %-1.32 %-1.05 %+55.73 %
USA/HEALTH CARE-1.12 %-1.95 %-5.36 %-7.44 %+49.43 %
USA/PHARMACEUTICALS-0.06 %+0.53 %-1.25 %-2.57 %+45.93 %
Data delayed at least 15 minutes, as of Jun 29 2016 18:53 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.